Severe cholestasis and renal failure associated with the use of the designer steroid Superdrol (methasteron): a case report and literature review.
Nasr
John
J
Department of Internal Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA.
Ahmad
Jawad
J
D000328:Adult; D045930:Anabolic Agents / Q000009:adverse effects*; D000982:Antipruritics / Q000627:therapeutic use; D001663:Bilirubin / Q000097:blood; D001706:Biopsy; D002756:Cholagogues and Choleretics / Q000627:therapeutic use; D002779:Cholestasis / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology; D003404:Creatinine / Q000097:blood; D019587:Dietary Supplements / Q000009:adverse effects*; D006801:Humans; D008099:Liver / Q000187:drug effects* / Q000473:pathology; D008297:Male; D011537:Pruritus / Q000139:chemically induced; D051437:Renal Insufficiency / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014891:Weight Lifting
D045930:Anabolic Agents; D000982:Antipruritics; D002756:Cholagogues and Choleretics; D003404:Creatinine; D001663:Bilirubin